BackEvaxion Biotech A/S Overview

Evaxion Biotech A/S Total Liabilities

Latest total liabilities for EVAX: $9.8M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.85M
↓ 39.29% YoYΔ $-6.37M vs prior year quarter

Peer trimmed avg / median

Loading

Evaxion Biotech A/S Total Liabilities History

Loading

Evaxion Biotech A/S vs. peers: Total Liabilities Comparison

Loading

Evaxion Biotech A/S Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evaxion Biotech A/S (EVAX) FAQ

As of the most recent data (June 2026), EVAX shows a total liabilities of $9.8M. That compares with $16M in the prior-year period — down 39.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EVAX's total liabilities is now $9.8M (was $16M) — a 39.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Evaxion Biotech A/S is outperforming or lagging.

Tracking EVAX's total liabilities over time shows whether Evaxion Biotech A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $9.8M That compares with $16M in the prior-year period — down 39.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Evaxion Biotech A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $9.8M) with ownership activity and broader fundamentals.

Evaxion Biotech A/S's total liabilities is $9.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.